Cellectis (CLLS) Gross Margin Growth (3y) (2018 - 2023)
Powered by 
Analysis
Cellectis (CLLS) Gross Margin Growth (3y) (2018 - 2023) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -230.00 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -168.00 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -65.00 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 14,836.00 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 589.00 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 53.00 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 569.00 |
| 10 | Cellectis | 321.90 Mn | 155.05 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | 25,815.00 |
| Sep 30, 2023 | -11,022.00 |
| Jun 30, 2023 | 17,003.00 |
| Mar 31, 2023 | -23,111.00 |
| Dec 31, 2022 | 2,805.00 |
| Sep 30, 2022 | -15,957.00 |
| Jun 30, 2022 | 4,557.00 |
| Mar 31, 2022 | -4,151.00 |
| Dec 31, 2021 | -2,621.00 |
| Sep 30, 2021 | -1,503.00 |
| Jun 30, 2021 | -9,410.00 |
| Mar 31, 2021 | -9,957.00 |
| Dec 31, 2020 | -12,117.00 |
| Sep 30, 2020 | -11,726.00 |
| Jun 30, 2020 | -10,415.00 |
| Mar 31, 2020 | -16.00 |
| Dec 31, 2019 | -12,499.00 |
| Sep 30, 2019 | -5,003.00 |
| Jun 30, 2019 | -2,200.00 |
| Mar 31, 2019 | -5,036.00 |